Prism Medical

Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS

Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma

Exclusive Financial Advisor (Buy side)